The distribution volume ratio (DVR), which is a linear function of receptor availability, is widely used as a model parameter in imaging studies. The DVR corre sponds to the ratio of the DV of a receptor-containing region to a nonreceptor region and generally requires the measurement of an arterial input function. Here we pro pose a graphical method for determining the DVR that does not require blood sampling. This method uses data from a nonreceptor region with an average tissue-to plasma efflux constant K2 to approximate the plasma in tegral. Data from positron emission tomography studies with [11C]raclopride (n = 20) and [IIC]d-threo methylphenidate ([IIC]dMP) (n = 8) in which plasma data were taken and used to compare results from two graph ical methods, one that uses plasma data and one that does not. K2 was 0.163 and 0.051 min -I for C IC]raciopride and [llC]dMP, respectively. Results from both methods were
Most techniques currently in use to quantify pos itron emission tomography (PET) images involve arterial blood sampling to construct an input func tion for the determination of model parameters. This is an invasive procedure that places stress on certain classes of patients, particularly the elderly, and can also present an added risk to health work ers when studying subjects in high-risk categories for HIV and other blood-borne infections. For these reasons, we have investigated the possibility of eliminating blood sampling from some studies with receptor ligands for which we routinely report a dis-very similar, and the average percentage difference be tween the methods was -0.11 % for [IIC]raciopride and 0.46% for [IIC]dMP for DVR of basal ganglia (BG) to cerebellum (CB) . Good agreement between the two meth ods was also achieved for DVR images created by both methods. This technique provides an alternative method of analysis not requiring blood sampling that gives equiv alent results for the two ligands studied. It requires initial studies with blood sampling to determine the average ki netic constant and to test applicability. In some ca<>es, it may be possible to neglect the K2 term if the BG/CB ratio becomes reasonably constant for a sufficiently long pe riod of time over the course of the experiment. Key Words: Distribution volume-Graphical analysis Methylphenidate-Positron emission tomography Raclopride.
tribution volume ratio (DVR) that is the ratio of the DV in a receptor region to the DV in a non receptor-containing region. The DV is a linear func tion of free receptor concentration and is therefore frequently used as a parameter of comparison for studies with reversibly binding radiotracers (Dewey et aI., 1993; Holtoff et aI., 1991; Koeppe et al., 1991; Carson et al., 1993) . The DV is also proportional to the ratio of transport constants (plasma to tissue and tissue to plasma), which is a function of plasma protein binding (Carson et al., 1993; Logan et al., 1994) . The dependence upon plasma protein binding is eliminated by taking the ratio of DVs from a re ceptor-containing region to a nonreceptor region . There are several approaches to the determination of the DV, but they all require some amount of blood sampling and the determina tion of a metabolite correction for the total radioac tivity to obtain a measure of the amount of un changed radiotracer in plasma (Logan et al., 1990; Koeppe et aI. , 1991; Carson et aI., 1993) . In this study, we compute directly the DVR, which is the parameter we use in assessing receptor availability with a modification of the graphical method (requir ing the plasma integral for unchanged tracer at each scan time) (Logan et aI., 1990) . In this modified method, PET data from a non-receptor-containing region and an average effective tissue-to-plasma ef flux constant (k2) for that region are used to approx imate the plasma integral. The use of the average k2 (/(2) minimizes the small time dependence of the re gion-of-interest (ROJ) ratio of receptor to non receptor regions. A similar approach in which plasma data were replaced with data from a non receptor region was suggested by Patlak and Blas berg (1985) in the graphical analysis of irreversible ligands. Recently Ichise et al. (1995) have proposed methods for obtaining the DVR without blood sam pling using [, 2 3I]iodobenzofuran with single photon emission computed tomography, although no com parison with results using plasma data was given. Lammertsma et al. (1996) have also proposed a method without blood sampling applied to PET studies with l l 'C]raclopride. This method uses the cerebellum (CB) as a reference region but also re quires a nonlinear regression analysis to determine four parameters including BmajKd' We have applied this graphical method for revers ible ligands to C 1 C]raclopride (Farde et aI., 1985) , which binds to dopamine (DA) D2 receptors, and to ['IC]d-threo-methylphenidate ([,'C]dMP) (Ding et aI., 1994) , which binds to the DA transporter. The kinetics of these ligands differ due to differences in rates of washout from the non-receptor regions (a result of differences on the order of a factor of 3 in k2).
The calculation of the DVR is compared using the measured arterial plasma input function and the method based on the non-receptor region. In these studies an ROI from the CB was used as the non receptor region since there is negligible concentra tion of DA receptors or transporters in this region.
THEORY AND METHODS
The equation used in the graphical analysis of revers ible systems (Logan et aI., 1990) is given by
where A ( t ) is the radioactivity measured by the PET cam era at time t in a specified ROI (averaged over some num ber of pixels) or in a single pixel and Cp( t ) is the radioac tivity in plasma due to unmetabolized radioligand. If a time t * can be found such that the time dependence of the intercept is sufficiently small, then for times T > t *, the D V can be found as the slope of a plot of g' A ( t )d t l A (n vs. J� Cp( t )d t I A (n. The time t * can be determined as the time after which no further significant increases in slope are observed.
To distinguish the� non-receptor region, the graphical analysis equation can be written as in which CB is used to designate the radiotracer concen tration in the non-receptor region. For the ligands used in these studies, CB is an ROI from the cerebellum. The D V and intercept are A and -I i k 2' respectively. Although Eq. 2 does not specify a particular model, the uptake and loss of ligand in the absence of receptors can generally be described by a two··compartment model (Wong et aI., 1984) :
where K I is the plasma-to-tissue influx constant, which is a function of blood flow, the permeability-surface area, and plasma protein binding, and k 2 is the efflux constant, also a function of non-specific binding. For the two compartment model, A = K/ k 2• Rearranging Eq. 2 and representing the intercept in Eq. 2 as -I / k 2 in place of
Substituting for g Cpd t in Eq. I gives
receptor concentration (receptors not occupied by endog enous neurotransmitter) and K� is the effective equilib rium dissociation constant (K� = Kul f NS ' wherej;"s is the free fraction of tracer) (Logan et aI., 1994) . Replacing k 2 in Eq. 5 with its average value k 2'
where B is the error term given by B = D VR( l l k 2 -J l k ,)CB(1)I A (1) and CB(1)I A (1) � J l D VR so that the time dependence of the error term should be small after some time t *. The slope determined from the linear por tion of a plot of (for T> t *) J(� A
( t )d t I A
(n vs. [J� CBd t + CB(nl k 2 J / A (n gives directly the D VR of the ROI to that of the CB. The D VR can also be obtained without the use of k 2 if the ratio A (n/CB(n is reasonably constant, that is, so that the intercept is now .,
Although it would be simpler to use the ratio A(1)/CB(1) as the DVR, it does not, in fact, represent the true DVR even when constant except in special cases. This is be cause the ti�sue-to-plasma ratio A(1)/Cp(1) is a function of the exponent describing the decline in plasma radioac tivity with time. For a three-compartment model, this can be expressed (see Table 5 , Logan et aI. , 1990) as
where the eigenvalues u± are given by (1) gives a value larger than the DV. For non-receptor re gions, the smallest eigenvalue should be greater than for the receptor region so that the ratio CB(1)/Cp(1) may be closer to the true DV. In any case, the ratio A(1)/CB (1), even when it becomes constant, will generally overesti mate the DVR. These problems can be avoided by using a controlled infusion rate of the tracer (Patlak and Petti grew, 1976; Carson et a\. , 1993) , but this is experimentally more complex than the bolus injection method upon which this work is based.
We have investigated the limits of applicability of this graphical method using two reversible ligands with differ ent kinetics in the rate of loss from non-receptor regions, which is controlled by k2• All data used in these calcula tions were from human studies with [llC]raclopride (Volkow et aI. , 1994) and [llC]dMP (Volkow et aI., 1995) and carried out on a whole-body, high-resolution positron emission tomograph (Cn 931; 15 planes, transaxial full width at half-maximum 6.5 mm, interslice distance 6.7 mm). Transmission scans were obtained to correct for attenuation . . Arterial blood sampling was done for all studies. The amount of unchanged tracer present in plasma wa� determined by solid phase extraction using a laboratory robot (Alexoff et aI. , 1995) . Experimental de tails for these studies can be found in Volkow et a\. ( , 1995 .
Since the greatest uptake of these two ligands is in the basal ganglia (BG), which has a large concentration of both DA D2 receptors and transporters, ROI calculations were limited to this structure. Regions with less uptake would be subject to smaller error since the ratio CB(1)/ A(1) for these regions would approach a constant value (steady state) in a shorter time. For use in the DVR cal culation, average values of k2 for [llC]raclopride (n = 20) and [I1C]dMP (n = 8) were determined graphically with measured plasma input functions and used in Eq. 7. (Al though the designation "k2" is used to be consistent with the terminology of the two-compartment model, the as sumption of a two-compartment model for CB is not nec essary since k2 was calculated graphically frOID the inter cept.) To assess the sensitivity of the value of k2 used, we calculated the DVR without the correction using Eq. 7 and for a range of k2 values for [I1C]dMP.
J Cereb Blood Flow Metab, Vol. 16, No.5, 1996 A more general comparison was made by constructing parametric images of the DVR. In this case, instead of an ROI, calculations were done for each pixel in the recon structed image falling within the brain. That part of the field of view falling within the brain was determined by masking the reconstructed images with a binary represen tation of the brain shape for each plane. These binary images were obtained by averaging scans up to 6 min and applying a cutoff of 0.25 of the maximum value in the plane to separate brain from nonbrain and to create a binary image. The brain area was filled in using morpho logical transformations. Image calculations were done us ing pixels falling within this binary image. For compari son, DVR images were generated by first constructing DV images using the measured plasma input function and Eq. I. These were then divided by the DV of the CB ROI to create DVR images. For both the [I1C]raclopride BG data and the DVR images, the slopes of the graphical analysis were determined as the average of slopes for times 22-60, 22-55, 27-60, and 27-55 (min) . For [IlC]dMP the times used in the calculation of DVRs were 29-75 and 29-60 (min). These times were chosen by observing the times at which the plots became linear and the calculated slope appeared to be independent of the initial time. Av eraging over the different end time points was done to minimize any possible effect of statistical fluctuations due to lower count rates at the last time point. This was a potential problem mainly in the parametric image con struction, which is done on a pixel-by-pixel basis. No approximate blood volume correction was made in the data prior to the DVR calculations using plasma data since it was not possible to make a blood volume correc tion using the graphical technique presented here. Com parison with data for which a blood volume correction has been made indicates a systematic difference between the methods.
RESULTS AND DISCUSSION
[IIC]Raciopride exhibits rapid clearance from non-receptor regions with /(2 in CB of 0.163 ± 0.036 min -I, which corresponds to a half-time of 4 min, while e IC]dMP exhibits a slower loss from non receptor regions /(2 = 0.051 ± 0.007 min -\ , with a half-time of 13 min. It is this clearance constant that controls how rapidly the non-receptor region reaches a steady state, although as discussed pre viously, a constant tissue-to-plasma ratio does not necessarily yield the true DV particularly for recep tor regions. For example, for raclopride the BG/CB ratio at the last scan time (60 min) exceeds the DVR determined using plasma and tissue uptake data by an average of 12 ± 6%. Although it would be ex pected that the BG/CB ratios for dMP would exceed the DVR to an even greater extent, they were found to be 5 ± 10% at the last time point, probably indi cating that the BG/plasma ratio had not quite reached a constant value. In any case when using bolus injection protocols, some modeling technique such as the one described here is required to deter mine the DVR.
A summary of the comparison of DVRs using both graphical techniques for ROls from the BG is presented in Table 1 . The average percentage change between DVRs calculated using the CB with the average k2 and the DVR calculated from the ratio of DVs determined using the measured plasma integral is close to 0 for both e IC]raclopride and e IC]dMP. The absolute percentage difference is slightly higher for [IIC]dMP although still small. The small percentage differences are indicative of random errors with little or no systematic error in troduced with the use of an average k2• The greater sensitivity of dMP to the value of k2 used in the DVR analysis is apparent in the difference between results calculated using Eq. 6 compared with Eq. 7. The average percentage change for dMP between the DVR calculated using plasma data and that cal culated from CB data without k2 is -12% compared with -1.8% for raclopride. The same difference (12 and 2% for dMP and raclopride, respectively) is ob served when comparing absolute values of percent age change, indicating the tendency to underesti mate the DVR when the k2 term is not included in Eq. 7. The difference between the result with and without the term CB(1)lk2 is minimized by extend ing to somewhat later times the initial time for the slope calculation so that the ratio A(T)/CB(T) (which is included in int' in Eq. 7) is changing slowly with time. The intercept (int in Eqs. 1, 5, 6) becomes effectively constant before A(1)ICp(1) [or A(1)ICB(1)] becomes constant (see Logan et aI., 1990 ) so that earlier time points can be used when calculating the DV or the DVR using Eq. 6.
The variation of the DVR with deviations of k2 from the average value was investigated with sim ulations. Simulated CB data representative of dMP were generated using Eq. 3 with A = K l lk2 = 9.2 and varying k2 from a baseline value of 0.051 min -1 by ±25 and + 50%, maintaining A constant. The DVR for a BG ROI was then determined using the simulated CB data but with the average k2 value (0.051 min -I) instead of the value actually used to generate the data. The variations in the DVR from the "true" value (2.96) are presented in Table 2 . DVR calculations were done with simulated CB data varying k2 but with experimental BO data. 0% refers to DVR calculations done with the "correct" k2' the k2 used to generate the CB data. See text for abbreviations. " By extending the initial time at which the slope is calculated to 39 min, the DVR agre,!s very well with the "correct" value. The small deviation between these values is no doubt due to fluctuations in the experimental BO data since different time points were used in the slope calculation.
Variations of ±25% from the original k2 value of 0.051 min -1 resulted in changes in the DVR of 3-4%. Most values of k2 would be expected to fall within this range given that the coefficient of vari ation (SD/avg x 100) for dMP is on the order of 15. Therefore, only small random errors would be ex pected to result from the use of the CB ROI with average k2 in place of the measured plasma input function. By extending the times for which the slope was calculated to 39-75 min, the DVR for [IIC]dMP was found to be within 2% of the "true" value with even a 50% increase in k2• Similar cal culations were not done for e IC]raclopride since the difference in DVR with and without k2 was small.
The graphical technique described here depends upon the substitution of the plasma integral with equivalent data from a non-receptor ROl. Figures 1  and 2 compare the integrated plasma radioactivity (filled circles) from studies with [IIC]raclopride and [IIC]dMP, respectively, with (1/A)[f� CB(t)dt + CB(T)lk2] (open circles) and with (1/A)f� CB(t)dt (triangles). It would appear that using (lIA) f� CB(t)dt in place of (1/A)[f6' CB(t)dt + CB(T)lk2] or the integrated plasma radioactivity should intro duce significant error into the calculation of the DVR. However, from Figs. 3 and 4 , which compare the graphical analysis using (1/A)[f6' CB(t)dt + CB(nik:J with that using (I/A)jZ' CB(t)dt, the slope (DVR) is not greatly affected. The difference in the DVRs for [IIC]raclopride (the slopes of the plots illustrated in Fig. 3 ) is -2% [3.24 with CB(n!ko and 3.16 without this term]. For [ 1 'C]dMP (Fig. 4 ) -, the difference in slope is larger, 2.94 including the CB(n!k2 term and 2.73 without it for a 7% decrease. From Eq. 9, the difference appears in the intercept, which for dMP is -18.5 min [without CB(J)!k2] compared with -43.7 min. For later times, CB(n! A(n (which appears in 0 in Eq. 7) is slowly varying function of time, which is why leaving out the term CB(n!k2 does not have as great an effect on the calculation of the DVR as might be expected. By including the term CB(n!k2 explicitly in the slope calculation, the time dependence of the intercept is minimized since the error term 0 is proportional to (l!k2 -l!k2) instead of IIk2• While the inclusion of J Cereb Blood Flow Me/ab. Vol. 16, No.5, 1996 Fig. 5 . The upper images were generated using the standard graphical technique and divided by the DV of the CB. The lower images were generated by the technique described here. The DVRs obtained by the two methods were compared by linear regres sion using Y = A + BX where Y is the pixel value from the DVR image generated with plasma data and X is the pixel value from the method using the CB ROl. The results are given in Table : raclopride and Table 4 for ["C]dMP (images for [II C]dMP are not shown). The agreement between the two methods was excellent.
["C]dMP showed slightly more variability than raclopride.
CONCLUSIONS
This method of using a non-receptor ROI in place of a measured plasma integral has been shown to give the same results for the DVRs as the graphical method using plasma data for the ligands ["C]_ raclopride and [IIC]dMP. Since the DVR is the pa rameter we use for the comparison of changes in receptor availability, we can obtain the same infor mation without blood sampling. Before implement ing this method for other ligands, it is necessary to do a set of baseline studies to establish an average A and B refer to the intercept and slope of the regression line Y = A + BX. where Y is the pixel value from the image generated with the method using measured plasma data and X is the pixel value from the method using the CB ROJ. The correlation coemcient is r; the average values for the DVRs from the two methods are designated DVR, (with plasma data) and DVR2 (using CB data). The maximum values from the images are given by Max, and Max2. See text for other abbreviations. k2 and determine the initial time at which the slope should be calculated. In some cases, the use of 1<2 may not be necessary if the experimental times at which the DVR is calculated are such that the time dependence of CB(DIA(D is sufficiently small. Also, adjusting the initial time at which the slope is calculated minimizes the time dependence of the intercept as was found for ["C]dMP, but this will also depend upon the half-life of the radioactive iso tope and amount of radioactivity injected. This graphical technique provides a simple method for obtaining DVRs and is not sensitive to fluctuations of k2 from the average value used in its calculations. In this respect, it is similar to the use of average kinetic constants in the determination of glucose metabolic rates in deoxyglucose models (Sokoloff et aI., 1977) . 
